Research analysts at Maxim Group assumed coverage on shares of Ellex Medical Las (OTCMKTS:ELXMF) in a note issued to investors on Wednesday, MarketBeat.com reports. The firm set a “buy” rating and a $1.50 price target on the stock. Maxim Group’s price target indicates a potential upside of 89.87% from the company’s previous close.

Ellex Medical Las (OTCMKTS:ELXMF) remained flat at $$0.79 during trading on Wednesday. Ellex Medical Las has a 12 month low of $0.75 and a 12 month high of $1.05.

TRADEMARK VIOLATION NOTICE: This article was first published by American Banking News and is owned by of American Banking News. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at https://www.americanbankingnews.com/2017/12/06/ellex-medical-las-elxmf-now-covered-by-analysts-at-maxim-group.html.

Receive News & Ratings for Ellex Medical Las Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ellex Medical Las and related companies with MarketBeat.com's FREE daily email newsletter.